Table 2.
Summary of the extent of disease identified over the course of follow-up for patients in this series.
| Tumor characteristics for patients included in this study | ||||||||
|---|---|---|---|---|---|---|---|---|
| Metastatic Sites | ||||||||
| Patient | Primary Site | Bone | Neck/Regional Nodes | Liver | Lung | Brain | Spleen | Eye |
| 1 | Carotid body | + | + | |||||
| 2 | Middle fossa/Cavernous sinus | + | ||||||
| 3 | Jugulotympanic | + | + | + | ||||
| 4 | Jugulotympanic | + | + | |||||
| 5 | Carotid body | + | + | |||||
| 6 | Carotid body | + | + | |||||
| 7 | Carotid body | + | ||||||
| 8 | Jugulotympanic | + | + | + | ||||
| 9 | Carotid body | + | + | + | ||||
| 10 | Jugulotympanic | + | ||||||
| 11 | Carotid body | + | + | + | + | |||
| 12 | Jugulotympanic | + | ||||||
| 13 | Carotid body | + | ||||||
| 14 | Carotid body | + | + | + | ||||
| 15 | Carotid body | + | + | |||||
| 16 | Jugulotympanic | + | ||||||
| 17 | Carotid body | + | + | |||||
| 18 | Carotid body/Glomus vagale | + | ||||||
| 19 | Parotid | + | + | |||||